NCT04368065View on ClinicalTrials.gov

COVID-19 Active Research Experience (CARE)

CompletedOBSERVATIONAL

Enrollment

35,278

Participants

Timeline

Start Date

April 2, 2020

Primary Completion Date

February 23, 2023

Study Completion Date

February 23, 2023

Conditions

COVID-19

Trial Locations (2)

02139

IQVIA, Cambridge

Unknown

IQVIA, London

All Listed Sponsors

lead

Iqvia Pty Ltd

INDUSTRY

NCT04368065 - COVID-19 Active Research Experience (CARE) | Biotech Hunter | Biotech Hunter